title: Safety and efficacy of high-dose droperidol in agitated patients.
authors.forename: M P
authors.initials: MP
authors.lastname: Szuba
authors.forename: K S
authors.initials: KS
authors.lastname: Bergman
authors.forename: L R
authors.initials: LR
authors.lastname: Baxter
authors.forename: B H
authors.initials: BH
authors.lastname: Guze
authors.forename: C A
authors.initials: CA
authors.lastname: Reynolds
authors.forename: L R
authors.initials: LR
authors.lastname: Pelletier
mesh_terms: D000208:Acute Disease; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000523:psychology; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology
chemical_list: D004329:Droperidol